Uncategorized

FDA posts new rejection letters days after confirming pause

Published

on

The FDA last week confirmed that it would suspend the release of complete response letters pending the resolution of a citizen petition from an unnamed pharma company. Nevertheless, 14 new CRLs are now available on the agency’s portal.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version